mTORC1 is a master regulator of cell growth and proliferation, and an established anticancer drug target. Aberrant mTORC1 signaling is common in hepatocellular carcinoma (HCC), but the underlying mechanism remains elusive. Rab1A is a newly identified mTORC1 activator that mediates an alternative amino acid (AA) signaling branch to Rag GTPases.
View Article and Find Full Text PDFZhongguo Zhong Xi Yi Jie He Za Zhi
October 2013
Objective: To observe the clinical effect on treatment of premature ovarian failure (POF) patients by Bushen Tiaojing Recipe (BTR) and hormone replacement therapy (HRT).
Methods: Totally 72 POF patients were randomly assigned to three groups by random digit table, i.e.